Medimpex United Inc. products

The EtG 300 Alcohol Test Dip Card is an innovative testing solution designed for employment, insurance, and forensic use. This product offers a rapid, lab-like testing experience for alcohol detection in urine, measuring the presence of ethyl glucuronide (EtG) with a cut-off level of 300 ng/ml. Traditionally available only in laboratories, this dip card now provides users with quick and reliable results in minutes without compromising accuracy. It detects alcohol consumption up to 80 hours, significantly extending the detection window compared to other instant tests. While intended for legal and professional use, it is notable that the test is not FDA 510k Cleared, making it unsuitable for diagnosing any health conditions. The test is straightforward to interpret, showing distinct colored lines for negative, positive, and invalid results. Users are advised to follow the test protocol precisely to avoid errors.

Gabapentin (GAB) urine test is designed to confirm the presence of gabapentin, a medication commonly prescribed to manage epilepsy and neuropathic pain. Neurontin, the branded form, is used to treat partial seizures and effectively addresses nerve pain related to conditions like diabetic neuropathy and postherpetic neuralgia. Despite its therapeutic benefits, gabapentin is often misused in combination with opioids, enhancing the opioid effect and potentially increasing the risk of dependency. The urine lab test offers reliable detection but is not admissible in legal settings. The testing process is handled by an outside lab, and results are communicated via email. It's crucial for safety monitoring and ensuring compliance with prescribed therapeutic use. The test aids healthcare providers in distinguishing therapeutic use from abuse. Common side effects of gabapentin include dizziness and fatigue, with more severe risks like increased suicide ideation and aggressive behaviors.